CD99 and neoplasm: The unmapped subset in Clu-CD34 uniquely expressed several leukemia-related genes (Figure 2C), one of which was CD99. This gene is known for playing key roles in promoting the mobilization of the hematopoietic cells [16–18] and has been recognized as a robust marker and promising therapeutic target in several tumor types [19].